Phase I trial of oral 2'-deoxy-2'-methylidenecytidine: on a daily x 14-day schedule.
Masuda N, Matsui K, Yamamoto N, Nogami T, Nakagawa K, Negoro S, Takeda K, Takifuji N, Yamada M, Kudoh S, Okuda T, Nemoto S, Ogawa K, Myobudani H, Nihira S, Fukuoka M.
Masuda N, et al. Among authors: kudoh s.
Clin Cancer Res. 2000 Jun;6(6):2288-94.
Clin Cancer Res. 2000.
PMID: 10873079
Clinical Trial.